Preoperative paclitaxel and radiotherapy for locally advanced breast cancer: Surgical aspects

Annals of Surgical Oncology

Volumn 7, Issue 2, 2000, Pages 145-149

  Skinner, Kristin A ^a,b   Silberman, Howard ^c   Florentine, Barbara ^b   Lomis, Thomas J ^a   Corso, Francesca ^b   Spicer, Darcy ^b   Formenti, Silvia C ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NONE

Author keywords

Locally advanced breast cancer; Mastectomy; Paclitaxel; Radiotherapy; Surgical morbidity

Indexed keywords

ANTIBIOTIC AGENT; PACLITAXEL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELLULITIS; CLINICAL ARTICLE; FEMALE; HUMAN; MASTECTOMY; MASTITIS; PREOPERATIVE TREATMENT; TISSUE NECROSIS; TREATMENT OUTCOME;

EID: 0034069720     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0145-3     Document Type: Article

References (25)

1. Lippman ME, Sorace RA, Bagley CS, et al. Treatment of Locally Advanced Breast Cancer Using Primary Induction Chemotherapy With or Without Debulking Surgery, vol 1. NCI Monograph, 1986:153-9.
2. Swain SM, Sorace RA, Bagley CS, et al. Neoadjuvant chemotherapy in the combined modality approach of locally advanced non-metastatic breast cancer. Cancer Res 1987;47:3889-94.
3. Hortobagyi GN, Buzdar AU. Locally advanced breast cancer: a review including the M. D. Anderson experience. In: Ragaz J, Ariel IM, eds. High-Risk Breast Cancer Therapy. Berlin: Springer-Verlag, 1991;382-415.
4. Holmes F, Valero V, Walters J, et al. The MD Anderson Cancer Center Experience with Taxol and Metastatic Breast Cancer, vol 15. NCI Monograph, 1993:161-9.
5. Seidman A, Reichman B, Crown J, et al. Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response. J Clin Oncol 1995;3:1152-9.
6. Nabholtz J, Gelmon K, Bontenbal M, et al. Randomized trial of two doses of paclitaxel in metastatic breast cancer. J Clin Oncol 1996;14:1858-67.
7. Wilson W, Berg S, Kang Y, et al. Phase I/II study of 96-hour infusion in refractory lymphoma and breast cancer. J Clin Oncol 1996;14:1858-67.
8. Mamounas E, Brown A. Fisher B. et al. Three hour, high-dose taxol infusion in advanced breast cancer (ABC): an NSABP phase II study (abstract). Proc Am Soc Clin Oncol 1995;15:127.
9. Abrams J, Vena D, Baltz J, et al. Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Referral Center Trial. J Clin Oncol 1995;13:2056-65.
10. Bishop J, Dewar J, Toner G, et al. A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand. Semin Oncol 1997;24(Suppl 17):S17-5-S17-9.
11. Buzdar A, Hortobagyi G, Asmar L, et al. Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer. Semin Oncol 1997;25(Suppl 17):S17-31-S17-34.
12. Formenti SC, Fraser S, Volm M, et al. Concurrent paclitaxel and radiation therapy for breast cancer. Semin Radiat Oncol 1999; 9(Suppl 1):34-42.
13. Formenti SC, Danenberg PV. Paclitaxel-induced radiosensitization: myth or reality? Adv Oncol 1999;5:25-9.
14. Formenti SC, Skinner KA, Spicer D, et al. Paclitaxel with concomitant radiation therapy in locally advanced breast cancer (LABC): clinical and pathological response. J Clin Oncol (in press).
15. Bonadonna G, Veronesi U, Brambilla C, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990;82:1539-45.
16. Hortobagyi GN, Blumenschein GR, Spanos W, et al. Multimodal treatment of locoregionally advanced breast cancer. Cancer 1983; 51:763-8.
17. Schwartz GF, Birchansky CA, Komarnicky LT, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 1994;73:362-9.
18. Singletary SE, McNeese MD, Hortobagyi GN. Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 1992;69:2849-52.
19. Eltahir A, Heys SD, Hutcheon AW, et al. Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy. Am J Surg 1998;175:127-32.
20. Skinner KA, Dunnington G, Silberman H, et al. Preoperative 5-fluorouracil and radiation therapy for locally advanced breast cancer. Am J Surg 1997;174:705-8.
21. Donaldson S, Glick J, Wilbur J. Adriamycin activating a recall phenomenon after radiation therapy. Int J Radiat Oncol Biol Phys 1974;81:407-8.
22. Richardson D, Johnson S. Anthracyclines in haematology: preclinical studies, toxicity and delivery systems. Blood Rev 1997;11: 201-23.
23. Bokemyer C, Lampe C, Heneka M, et al. Paclitaxel-induced radiation recall dermatitis. Ann Oncol 1996;7:755-6.
24. McCarty M, Peake M, Lillis P, Vukelja S. Paclitaxel-induced radiation recall dermatitis. Med Pediatr Oncol 1996;27:185-6.
25. Raghavan V, Bloomer W, Merkel D. Taxol and radiation recall dermatitis (letter). Lancet 1993;341:1354.